Dr. Vicente Valero, MD
Claim this profileM D Anderson Cancer Center
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
21 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage IV
HER2 negative
2Breast Cancer
Stage IV
HER2 negative
HER2 positive
Affiliated Hospitals
Clinical Trials Vicente Valero, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Zanidatamab
for Early Stage HER2 Positive Breast Cancer
This is a Phase 2, single-site, single-arm open-label trial of zanidatamab in patients with early stage, low risk HER2+ BC. The primary objective is to determine the efficacy of zanidatamab for patients with early stage HER2/neu positive (HER2+) breast cancer (BC) as determined by pathologic complete response (pCR) .
Recruiting1 award Phase 210 criteria
More about Vicente Valero, MD
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Vicente Valero, MD has experience with
- Paclitaxel
- Atezolizumab
- Pertuzumab
- Trastuzumab
- Cobimetinib
- Eribulin
Breakdown of trials Vicente Valero, MD has run
Breast Cancer
Breast cancer
- M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer
- Chemotherapy Combinations for Triple-Negative Breast Cancer
- Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients with Inflammatory or Invasive Breast Cancer
Thyroid Cancer
Triple-Negative Breast Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vicente Valero, MD specialize in?
Vicente Valero, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Vicente Valero, MD currently recruiting for clinical trials?
Yes, Vicente Valero, MD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Vicente Valero, MD has studied deeply?
Yes, Vicente Valero, MD has studied treatments such as Paclitaxel, Atezolizumab, Pertuzumab.
What is the best way to schedule an appointment with Vicente Valero, MD?
Apply for one of the trials that Vicente Valero, MD is conducting.
What is the office address of Vicente Valero, MD?
The office of Vicente Valero, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.